课题基金 / 基金详情

HIGHLY ACTIVE ANTIRETROVIRAL THERAPY W/WO RHIL 2 FOR HIV POSITIVE PATIENTS

HIGHLY ACTIVE ANTIRETROVIRAL THERAPY W/WO RHIL 2 FOR HIV POSITIVE PATIENTS
针对 HIV 阳性患者的高活性抗逆转录病毒治疗(含 RHIL 2)
批准号:
6566719
负责人:
RICHARD B POLLARD
金额:
$27.93万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-12-01 至 2002-11-30

项目摘要

项目成果

RICHARD B POLLARD的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是确定白细胞介素-2(IL-2)与高效抗逆转录病毒疗法(HAART),抗艾滋病毒药物相结合的安全性,耐受性和有效性,与HAART单独相比,并确定IL-2与这种抗逆转录病毒疗法相结合的最佳途径。 HAART因其有效对抗HIV感染而被给予,由四种药物组合之一加上茚地那韦组成:ZDV +3 tc; ZDV+ddI; d4 T +3 TC;或d4 T +ddI。 IL-2是一种重要的物质,由人体的CD 4细胞自然产生。 HIV感染者不能产生足够的IL-2。 目前正在测试IL-2是否会增加CD 4细胞的数量并增强免疫系统。
英文摘要
The purpose of this research study is to determine the safety, tolerance and effectiveness of Interleukin-2 (IL-2) in combination with highly active antiretroviral therapy (HAART), drugs that fight HIV, compared to HAART alone and to determine the best route of giving IL-2 in combination with this antiretroviral therapy. HAART is being given for its effectiveness to fight HIV infection and consists of one of the four combinations of drugs plus indinavir: ZDV + 3tc; ZDV+ddI; d4T+3TC; or d4T+ddI. IL-2 is an important substance which is naturally produced by the body's CD4 cells. People with HIV do not produce enough IL-2. IL-2 is being tested to see if it will increase the number of CD4 cells and boost the immune system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NORTH-CENTRAL CALIFORNIA-CENTER FOR AIDS RESEARCH
  • 批准号:
    7562184
  • 项目类别:
  • 资助金额:
    $13.97万
  • 财政年份:
    2007
  • 负责人:
    RICHARD B POLLARD
  • 依托单位:
NORTH-CENTRAL CALIFORNIA-CENTER FOR AIDS RESEARCH
  • 批准号:
    7349680
  • 项目类别:
  • 资助金额:
    $3.91万
  • 财政年份:
    2006
  • 负责人:
    RICHARD B POLLARD
  • 依托单位:
NORTH-CENTRAL CALIFORNIA-CENTER FOR AIDS RESEARCH
  • 批准号:
    7165486
  • 项目类别:
  • 资助金额:
    $25.25万
  • 财政年份:
    2005
  • 负责人:
    RICHARD B POLLARD
  • 依托单位:
NORTH-CENTRAL CALIFORNIA-CENTER FOR AIDS RESEARCH
  • 批准号:
    6971489
  • 项目类别:
  • 资助金额:
    $42.47万
  • 财政年份:
    2004
  • 负责人:
    RICHARD B POLLARD
  • 依托单位:
海外基金